IP36-01: RBMX-mediated ac4C Modification of PD-L1 mRNA Drives RC48 Resistance in HER2-Positive Bladder Cancer by Fostering an Immunosuppressive Microenvironment

IP36-01: RBMX-mediated ac4C Modification of PD-L1 mRNA Drives RC48 Resistance in HER2-Positive Bladder Cancer by Fostering an Immunosuppressive Microenvironment

Saturday, May 16, 2026 9:30 AM to 11:30 AM · 1 hr. 59 min. (America/New_York)

147B

Abstract

Sessions

IP36: Bladder Cancer: Invasive I

Saturday, May 16, 2026 9:30 AM to 11:30 AM

Log in

See all the content and easy-to-use features by logging in or registering!